Repligen (RGEN) Tops Q2 EPS by 9c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $181.19 +4.76%
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Total operating expenses: 20.93M
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.54, $0.09 better than the analyst estimate of $0.45. Revenue for the quarter came in at $204 million versus the consensus estimate of $201.47 million.
Outlook:-
FY 2026 EPS between $2.03-$2.09 vs consensus $2.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Popular stocks option volume leaders: INTC ORCL IREN CRWV MRVL AVGO SOFI WULF
- Western Investment closes $55.8M private placement on TSX Venture Exchange
- WildBrain partners with EightyEight Pictures for CG animation production
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
